Spinal cord transient ischemic attacks: a possible role for abciximab

Neurology. 2005 Feb 22;64(4):761-2. doi: 10.1212/01.WNL.0000152051.18941.01.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Abciximab
  • Antibodies, Monoclonal / administration & dosage
  • Antibodies, Monoclonal / therapeutic use*
  • Aorta, Abdominal / surgery
  • Aortic Diseases / complications
  • Calcinosis / complications
  • Combined Modality Therapy
  • Drug Therapy, Combination
  • Femoral Artery / surgery
  • Heparin / administration & dosage
  • Heparin / therapeutic use
  • Humans
  • Immunoglobulin Fab Fragments / administration & dosage
  • Immunoglobulin Fab Fragments / therapeutic use*
  • Ischemia / complications
  • Ischemia / drug therapy*
  • Ischemia / surgery
  • Magnetic Resonance Imaging
  • Male
  • Middle Aged
  • Platelet Aggregation Inhibitors / administration & dosage
  • Platelet Aggregation Inhibitors / therapeutic use*
  • Sensation Disorders / drug therapy
  • Sensation Disorders / etiology
  • Spinal Cord / blood supply*
  • Thrombosis / complications
  • Thrombosis / drug therapy*
  • Urinary Incontinence / drug therapy
  • Urinary Incontinence / etiology
  • Warfarin / administration & dosage
  • Warfarin / therapeutic use

Substances

  • Antibodies, Monoclonal
  • Immunoglobulin Fab Fragments
  • Platelet Aggregation Inhibitors
  • Warfarin
  • Heparin
  • Abciximab